Organization · Venture Capital
Longview Innovation
Longview Innovation is a hard science investment firm based in Wilmington, Delaware, focused on creating companies from scientific discoveries. It partners with North American research institutions to commercialize transformative technologies.
Overview
What Longview Innovation does
What Longview Innovation is
Longview Innovation is a hard science investment firm based in Wilmington, Delaware, focused on creating companies from scientific discoveries. It partners with North American research institutions to commercialize transformative technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Longview Innovation elsewhere
Open the official website or a supported primary organization account.
Capability profile
Longview Innovation as a funder
Investment thesis
Longview Innovation specializes in commercializing transformative technologies derived from scientific research, focusing on early-stage companies in hard sciences that have the potential to disrupt existing industries or create new ones.
Focus narrative
Longview Innovation invests in companies that are grounded in scientific discovery, particularly in the hard sciences. The firm employs a disciplined process to validate and launch companies, aiming to establish disruptive, science-based commercial capabilities. Their investment strategy includes partnering with universities and national labs, and they focus on sectors that can benefit from advanced scientific research.
Value beyond capital
Longview Innovation adds value to its portfolio companies by leveraging partnerships with leading research institutions and national laboratories, providing access to advanced scientific research and expertise. The firm employs a disciplined approach to company validation and launch, ensuring that investments are grounded in solid scientific discovery.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Carisma Therapeutics: Focuses on harnessing engineered macrophages. Exyn Technologies: Specializes in multi-platform robotic autonomy for industrial data collection in complex environments. MOBILion Systems: Works on unraveling analytical complexity in various applications. EnaChip: Develops efficient power solutions for semiconductor microchips. Lumiode: Produces high-brightness micro-displays for augmented reality. Optimeos Life Sciences: Innovates in gene therapy through next-generation nanoparticle delivery. Somalytics: Develops novel carbon nanotube paper capacitive sensors for various applications.
Common questions
What to know about Longview Innovation
Upseed classifies Longview Innovation under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.